Experimental study of the serum and horny layer concentration shift in Ivermectin bath method
- Conditions
- scabies
- Registration Number
- JPRN-UMIN000013068
- Lead Sponsor
- Tokyo University of Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Not provided
1) The patient who has an obstacle in the barrier of the skin according to a skin disorder 2) Those who have the following diseases in the past or the present - Liver disease - The disease considered to affect a test result by a doctor in attendance in addition to this, or the disease considered that medication of ivermectin brings about a disadvantage 3) The superfluous ingestion person of the coffee containing caffeine, or a drink (>8 cup / day) 4) The abuse person of medicine or alcohol 5) The addict of an illegal drug 6) The woman who offered the blood of 400mL within the man and woman who offered the blood of 200mL within four weeks before the examination or the man who offered the blood of 400mL within 12 weeks, and 16 weeks 7) Those who participated in four weeks to the clinical test using other investigational new drugs before this start of test 8) Those who have an anamnesis of hypersensitivity in the ingredient of a StromectolⓇ Tablets or the charge of baby purification (Pigeon, Inc.) 9) The woman during pregnancy or potential pregnancy, and breast-feeding 10) Those whom the examination doctor in attendance judged to be unsuitable as a subject 11) Those who have used medication within a week
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -The concentration of Ivermectin in horny layer -The concentration of Ivermectin in blood
- Secondary Outcome Measures
Name Time Method -The concentration of Ivermectin in the bath solution -Toxic Epidermal necrosis -Stevens-Johnson syndrome -Impairment of liver function -Other adverse events